Inhibikase Therapeutics shares owned by Commodore Capital
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Commodore Capital
from 13F filings
Historical chart of Commodore Capital investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Commodore Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.7M | 5.4M | 1.62 |
| 2025-06-30 | $11M | 5.4M | 1.95 |
| 2025-03-31 | $12M | 5.3M | 2.19 |
| 2024-12-31 | $19M | 5.9M | 3.25 |